FGF21 and cyclic hematopoiesis: Strong evidence indicates that fibroblast growth factor (FGF)21 protects the heart from lipopolysaccharide-induced inflammation, isoproterenol-induced cardiac hypertrophy (CH), or ischemia–reperfusion-induced cardiac injury via activating antioxidative effects10,11.